Viewing Study NCT02113657

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:37 PM
Ignite Modification Date: 2026-01-04 @ 12:03 AM
Study NCT ID: NCT02113657
Status: COMPLETED
Last Update Posted: 2024-05-24
First Post: 2014-04-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Prostate cancer View
None Castration-resistant prostate cancer View
None CRPC View
None Metastatic View
None Hormone therapy treatment View
None Androgen deprivation therapy View
None gonadotropin-releasing hormone View
None GnRH View
None Ipilimumab View
None Yervoy View
None BMS-734016 View
None MDX010 View